In this signaling pathway, Smad7 is an inhibitory Smad (Bian et al., 2014), a negative feedback regulator in the TGF-β signaling pathway that can attenuate TGF-β1 induced HSCs activation and improve liver fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.